Jeff Welday - 31 Mar 2023 Form 5 Insider Report for Beneficient (BENF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
5
Accepted by SEC
11 Jun 2024, 19:28:13 UTC
Next SEC filing
07 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David B. Rost Attorney-in-fact for Jeff Welday

Key filing fact

Jeff Welday filed Form 5 for Beneficient (BENF) on 11 Jun 2024.

Key facts

  • This page summarizes Jeff Welday's Form 5 filing for Beneficient (BENF).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2024, 19:28.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BENF transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+354
Change %
+15%
Price
$0.000000
Shares after
2,663
Date
15 Jul 2023
Ownership
Direct
Footnotes
F1, F2, F3, F4
BENF transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+257
Change %
+9.7%
Price
$0.000000
Shares after
2,920
Date
15 Jul 2023
Ownership
Direct
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The shares shown have been retroactively adjusted to reflect Beneficient's (the "Issuer") reverse stock split of its outstanding shares of Class A common stock, par value $0.001 per share ("Class A common stock"), and Class B common stock, par value $0.001 per share, on a 1-for-80 basis effected on April 18, 2024.

Footnote F2

Includes 354 shares of Class A common stock issuable upon the settlement of an award of 354 restricted stock units ("RSUs") granted pursuant to Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Jeff Welday (the "Reporting Person") on July 15, 2023. Such award of RSUs to the Reporting Person vested 20% on September 1, 2023, and the remaining 80% in four equal annual installments on September 1st of each subsequent calendar year.

Footnote F3

Includes 2,196 shares of Class A common stock of the Issuer issuable upon the settlement of an award of 1,757 restricted equity units ("REUs") granted pursuant to The Beneficient Company Group, L.P. 2018 Equity Incentive Plan ("2018 Equity Incentive Plan") to the Reporting Person on January 1, 2020. Such award of REUs to the Reporting Person vested 20% on the date of grant, and the remaining 80% in four equal annual installments on June 3rd of each subsequent calendar year.

Footnote F4

Includes 113 shares of Class A common stock issuable upon settlement of an award of 90 REUs to the Reporting Person granted pursuant to the 2018 Equity Incentive Plan on April 1, 2022. Such award of REUs to the Reporting Person shall vest 40% on June 8, 2023, and the remaining 60% in three equal annual installments on April 1st of each subsequent calendar year.

Footnote F5

Includes 257 shares of Class A common stock of the Issuer issuable upon the settlement of an award of 257 RSUs granted pursuant to 2023 Equity Incentive Plan to the Reporting Person on July 15, 2023. Such award of RSUs to the Reporting Person fully vested on September 1, 2023.

SEC remarks

Global Head of Organizations and Distribution

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .